CN104237522A - 脂联素含量检测试剂盒及其制备方法 - Google Patents
脂联素含量检测试剂盒及其制备方法 Download PDFInfo
- Publication number
- CN104237522A CN104237522A CN201210508749.8A CN201210508749A CN104237522A CN 104237522 A CN104237522 A CN 104237522A CN 201210508749 A CN201210508749 A CN 201210508749A CN 104237522 A CN104237522 A CN 104237522A
- Authority
- CN
- China
- Prior art keywords
- reagent
- adiponectin
- latex
- antibody
- surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000011690 Adiponectin Human genes 0.000 title claims abstract description 125
- 108010076365 Adiponectin Proteins 0.000 title claims abstract description 125
- 238000001514 detection method Methods 0.000 title claims abstract description 95
- 238000002360 preparation method Methods 0.000 title abstract description 48
- 239000004816 latex Substances 0.000 claims abstract description 152
- 229920000126 latex Polymers 0.000 claims abstract description 152
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 102
- 239000002245 particle Substances 0.000 claims abstract description 85
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 72
- 239000004094 surface-active agent Substances 0.000 claims abstract description 29
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 22
- 239000003381 stabilizer Substances 0.000 claims abstract description 18
- 239000003223 protective agent Substances 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 15
- 239000000872 buffer Substances 0.000 claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims description 82
- 239000000243 solution Substances 0.000 claims description 60
- 230000009514 concussion Effects 0.000 claims description 46
- 239000012153 distilled water Substances 0.000 claims description 42
- 239000006177 biological buffer Substances 0.000 claims description 22
- 239000006228 supernatant Substances 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 20
- 239000003352 sequestering agent Substances 0.000 claims description 20
- 238000013016 damping Methods 0.000 claims description 19
- 239000012530 fluid Substances 0.000 claims description 19
- 238000001556 precipitation Methods 0.000 claims description 19
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 18
- 238000007789 sealing Methods 0.000 claims description 18
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 16
- 239000000375 suspending agent Substances 0.000 claims description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 10
- 230000001235 sensitizing effect Effects 0.000 claims description 10
- 239000004471 Glycine Substances 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 9
- 230000004913 activation Effects 0.000 claims description 8
- 239000007795 chemical reaction product Substances 0.000 claims description 8
- 239000013504 Triton X-100 Substances 0.000 claims description 5
- 229920004890 Triton X-100 Polymers 0.000 claims description 5
- -1 antiseptic Substances 0.000 claims description 5
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical group [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 150000001718 carbodiimides Chemical class 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 4
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 4
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- CCMKPCBRNXKTKV-UHFFFAOYSA-N 1-hydroxy-5-sulfanylidenepyrrolidin-2-one Chemical compound ON1C(=O)CCC1=S CCMKPCBRNXKTKV-UHFFFAOYSA-N 0.000 claims description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 claims description 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- 229940098773 bovine serum albumin Drugs 0.000 claims description 2
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 229960003330 pentetic acid Drugs 0.000 claims description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 229960003511 macrogol Drugs 0.000 claims 1
- 125000000647 trehalose group Chemical group 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 12
- 239000002738 chelating agent Substances 0.000 abstract 2
- 239000002981 blocking agent Substances 0.000 abstract 1
- 238000010382 chemical cross-linking Methods 0.000 abstract 1
- 230000015271 coagulation Effects 0.000 abstract 1
- 238000005345 coagulation Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 44
- 230000000052 comparative effect Effects 0.000 description 33
- 239000000523 sample Substances 0.000 description 21
- 239000007853 buffer solution Substances 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 230000006641 stabilisation Effects 0.000 description 6
- 238000011105 stabilization Methods 0.000 description 6
- 239000013068 control sample Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 238000003908 quality control method Methods 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000009931 harmful effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 239000003547 immunosorbent Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 150000001455 metallic ions Chemical class 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- RPENMORRBUTCPR-UHFFFAOYSA-M sodium;1-hydroxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].ON1C(=O)CC(S([O-])(=O)=O)C1=O RPENMORRBUTCPR-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- BHNQPLPANNDEGL-UHFFFAOYSA-N 2-(4-octylphenoxy)ethanol Chemical compound CCCCCCCCC1=CC=C(OCCO)C=C1 BHNQPLPANNDEGL-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 229920001219 Polysorbate 40 Polymers 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229940101027 polysorbate 40 Drugs 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
稀释倍数 | 测量值1 | 测量值2 | 测量均值 | 理论值 | 线性偏差(%) |
0.1 | 902 | 898 | 900 | 896 | 0.44 |
0.2 | 1794 | 1796 | 1795 | 1792 | 0.17 |
0.3 | 2671 | 2674 | 2672.5 | 2688 | -0.58 |
0.4 | 3602 | 3585 | 3593.5 | 3584 | 0.26 |
0.5 | 4452 | 4454 | 4453 | 4480 | -0.61 |
0.6 | 5405 | 5386 | 5395.5 | 5376 | 0.36 |
0.7 | 6314 | 6298 | 6306 | 6272 | 0.54 |
0.8 | 7164 | 7146 | 7155 | 7168 | -0.18 |
0.9 | 8076 | 8088 | 8082 | 8064 | 0.22 |
1.0 | 9056 | 8814 | 8935 | 8960 | -0.28 |
稀释倍数 | 测量值1 | 测量值2 | 测量均值 | 理论值 | 线性偏差(%) |
0.1 | 375 | 386 | 380.5 | 398.6 | -4.76 |
0.2 | 765 | 779 | 772 | 797.2 | -3.26 |
0.3 | 1059 | 1056 | 1057.5 | 1195.8 | -13.08 |
0.4 | 1508 | 1498 | 1503 | 1594.4 | -6.08 |
0.5 | 1902 | 1895 | 1898.5 | 1993 | -4.98 |
0.6 | 2401 | 2411 | 2406 | 2391.6 | 0.6 |
0.7 | 2706 | 2685 | 2695.5 | 2790.2 | -3.51 |
0.8 | 3256 | 3234 | 3245 | 3188.8 | 1.73 |
0.9 | 3605 | 3614 | 3609.5 | 3587.4 | 0.61 |
1.0 | 4128 | 4206 | 4167 | 3986 | 4.34 |
稀释倍数 | 测量值1 | 测量值2 | 测量均值 | 理论值 | 线性偏差(%) |
0.1 | 221 | 223 | 222 | 218.1 | 1.76 |
0.2 | 440 | 441 | 440.5 | 436.2 | 0.98 |
0.3 | 674 | 672 | 673 | 654.3 | 2.78 |
0.4 | 865 | 869 | 867 | 872.4 | -0.62 |
0.5 | 1085 | 1083 | 1084 | 1090.5 | -0.6 |
0.6 | 1296 | 1293 | 1294.5 | 1308.6 | -1.09 |
0.7 | 1520 | 1524 | 1522 | 1526.7 | -0.31 |
0.8 | 1751 | 1753 | 1752 | 1744.8 | 0.41 |
0.9 | 1971 | 1965 | 1968 | 1962.9 | 0.26 |
1.0 | 2196 | 2194 | 2195 | 2181 | 0.64 |
稀释倍数 | 测量值1 | 测量值2 | 测量均值 | 理论值 | 线性偏差(%) |
0.1 | 345 | 358 | 351.5 | 335.6 | 4.52 |
0.2 | 745 | 732 | 738.5 | 671.2 | 9.11 |
0.3 | 1102 | 1098 | 1100 | 1006.8 | 8.47 |
0.4 | 1414 | 1425 | 1419.5 | 1342.4 | 5.43 |
0.5 | 1732 | 1742 | 1737 | 1678 | 3.4 |
0.6 | 2156 | 2186 | 2171 | 2013.6 | 7.25 |
0.7 | 2432 | 2465 | 2448.5 | 2349.2 | 4.06 |
0.8 | 2738 | 2714 | 2726 | 2684.8 | 1.51 |
0.9 | 3078 | 3084 | 3081 | 3020.4 | 1.97 |
1.0 | 3578 | 3556 | 3567 | 3356 | 5.92 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210508749.8A CN104237522B (zh) | 2012-12-03 | 2012-12-03 | 脂联素含量检测试剂盒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210508749.8A CN104237522B (zh) | 2012-12-03 | 2012-12-03 | 脂联素含量检测试剂盒及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104237522A true CN104237522A (zh) | 2014-12-24 |
CN104237522B CN104237522B (zh) | 2016-12-21 |
Family
ID=52226012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210508749.8A Active CN104237522B (zh) | 2012-12-03 | 2012-12-03 | 脂联素含量检测试剂盒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104237522B (zh) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105181694A (zh) * | 2015-02-27 | 2015-12-23 | 北京利德曼生化股份有限公司 | 癌胚抗原胶乳增强免疫比浊试剂盒及其应用 |
CN105911293A (zh) * | 2016-05-26 | 2016-08-31 | 安徽伊普诺康生物技术股份有限公司 | 一种测定免疫球蛋白a的试剂盒及其制备方法 |
CN106018299A (zh) * | 2016-05-26 | 2016-10-12 | 安徽伊普诺康生物技术股份有限公司 | 一种测定血清淀粉样蛋白a的试剂盒及其制备方法 |
CN106053839A (zh) * | 2016-07-12 | 2016-10-26 | 安徽伊普诺康生物技术股份有限公司 | 一种测定结合珠蛋白的试剂盒及其制备方法 |
CN106093418A (zh) * | 2016-05-26 | 2016-11-09 | 安徽伊普诺康生物技术股份有限公司 | 一种测定肌钙蛋白i的试剂盒及其制备方法 |
CN106093423A (zh) * | 2016-05-31 | 2016-11-09 | 安徽伊普诺康生物技术股份有限公司 | 一种测定视黄醇结合蛋白的试剂盒及其制备方法 |
CN106353507A (zh) * | 2016-08-24 | 2017-01-25 | 武汉生之源生物科技股份有限公司 | 一种检测血清淀粉样蛋白的试剂盒及其用途 |
CN107102150A (zh) * | 2017-05-04 | 2017-08-29 | 上海奥普生物医药有限公司 | 一种尿微量白蛋白测定试剂盒及其制备方法 |
CN107478846A (zh) * | 2017-08-10 | 2017-12-15 | 迈克生物股份有限公司 | 一种免疫球蛋白g检测试剂盒及检测方法 |
CN107478853A (zh) * | 2017-08-10 | 2017-12-15 | 迈克生物股份有限公司 | 一种载脂蛋白b检测试剂盒及检测方法 |
CN107490676A (zh) * | 2017-08-10 | 2017-12-19 | 迈克生物股份有限公司 | 一种补体c3检测试剂盒及检测方法 |
CN107490675A (zh) * | 2017-08-10 | 2017-12-19 | 迈克生物股份有限公司 | 一种免疫比浊试剂盒及检测方法 |
CN107741492A (zh) * | 2017-09-30 | 2018-02-27 | 安徽伊普诺康生物技术股份有限公司 | 一种包被有n‑端脑利钠肽前体抗体的胶乳微球的制备方法 |
CN108548927A (zh) * | 2018-03-30 | 2018-09-18 | 武汉生之源生物科技股份有限公司 | 消除血清脂类干扰的胶乳免疫比浊法胃蛋白酶原ⅱ检测试剂盒及其制备方法 |
CN108956982A (zh) * | 2018-07-09 | 2018-12-07 | 广州华澳生物科技有限公司 | 一种类风湿性关节炎标志物联合定量检测试纸及其制备方法 |
CN109001464A (zh) * | 2018-07-09 | 2018-12-14 | 广州华澳生物科技有限公司 | 一种炎症标志物联合定量检测试纸及其制备方法 |
CN109001463A (zh) * | 2018-07-09 | 2018-12-14 | 广州华澳生物科技有限公司 | 一种胃癌风险标志物联合定量检测试纸及制备方法 |
CN109856067A (zh) * | 2019-01-11 | 2019-06-07 | 河北省医疗器械与药品包装材料检验研究院(河北省医疗器械技术审评中心) | 一种c反应蛋白测定试剂盒 |
CN110007091A (zh) * | 2019-04-02 | 2019-07-12 | 杭州博谱医药科技有限公司 | 一种脂联素检测试剂盒及其制备方法 |
CN110372783A (zh) * | 2019-04-15 | 2019-10-25 | 杭州博谱医药科技有限公司 | 一种脂联素抗原、抗体及其胶乳试剂的制备方法以及脂联素检测试剂盒 |
CN111239421A (zh) * | 2020-02-19 | 2020-06-05 | 安徽大千生物工程有限公司 | 一种定量检测脂联素adpn的胶乳增强免疫比浊试剂盒及其制备与应用方法 |
CN111337692A (zh) * | 2020-03-25 | 2020-06-26 | 江西乐成生物医疗有限公司 | 一种脂联素测定试剂及制备方法 |
CN111505317A (zh) * | 2020-04-21 | 2020-08-07 | 江西乐成生物医疗有限公司 | 脂联素测定试剂质控品及制备方法 |
CN112730827A (zh) * | 2020-12-11 | 2021-04-30 | 常州爱复康生物科技有限公司 | 一种新型冠状病毒抗体检测试剂盒及其制备方法 |
CN113049836A (zh) * | 2021-03-10 | 2021-06-29 | 深圳上泰生物工程有限公司 | 一种组合物及其脂联素检测试剂盒 |
CN114112957A (zh) * | 2021-11-26 | 2022-03-01 | 浙江夸克生物科技有限公司 | 一种脂联素测定试剂盒及其应用 |
CN114295840A (zh) * | 2021-12-29 | 2022-04-08 | 中元汇吉生物技术股份有限公司 | 一种高灵敏度定量测定脂联素的试剂盒及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002010760A1 (fr) * | 2000-07-27 | 2002-02-07 | Kyowa Medex Co., Ltd | Technique relative a une epreuve d'immunite menee avec des particules d'un vehicule insoluble et reactif a cet effet |
CN101968492A (zh) * | 2010-10-29 | 2011-02-09 | 厦门大学附属中山医院 | 检测脂联素的颗粒增强免疫透射比浊试剂盒及其制备方法 |
CN102161716A (zh) * | 2010-12-30 | 2011-08-24 | 北京九强生物技术股份有限公司 | 胶乳致敏的方法及试剂 |
CN202066863U (zh) * | 2010-10-29 | 2011-12-07 | 厦门大学附属中山医院 | 检测脂联素的颗粒增强免疫透射比浊试剂盒 |
CN102628864A (zh) * | 2011-12-30 | 2012-08-08 | 北京九强生物技术股份有限公司 | 胶乳增强免疫比浊法测定血清或尿液中心脏型脂肪酸结合蛋白的试剂盒 |
CN102680676A (zh) * | 2011-07-29 | 2012-09-19 | 南京诺尔曼生物技术有限公司 | 髓过氧化物酶(myeloperoxidase MPO)测定试剂盒(胶乳增强免疫比浊法) |
CN102692507A (zh) * | 2011-07-29 | 2012-09-26 | 南京诺尔曼生物技术有限公司 | 脂蛋白相关磷脂酶a2(lppla2)测定试剂盒(胶乳增强免疫比浊法) |
-
2012
- 2012-12-03 CN CN201210508749.8A patent/CN104237522B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002010760A1 (fr) * | 2000-07-27 | 2002-02-07 | Kyowa Medex Co., Ltd | Technique relative a une epreuve d'immunite menee avec des particules d'un vehicule insoluble et reactif a cet effet |
CN101968492A (zh) * | 2010-10-29 | 2011-02-09 | 厦门大学附属中山医院 | 检测脂联素的颗粒增强免疫透射比浊试剂盒及其制备方法 |
CN202066863U (zh) * | 2010-10-29 | 2011-12-07 | 厦门大学附属中山医院 | 检测脂联素的颗粒增强免疫透射比浊试剂盒 |
CN102161716A (zh) * | 2010-12-30 | 2011-08-24 | 北京九强生物技术股份有限公司 | 胶乳致敏的方法及试剂 |
CN102680676A (zh) * | 2011-07-29 | 2012-09-19 | 南京诺尔曼生物技术有限公司 | 髓过氧化物酶(myeloperoxidase MPO)测定试剂盒(胶乳增强免疫比浊法) |
CN102692507A (zh) * | 2011-07-29 | 2012-09-26 | 南京诺尔曼生物技术有限公司 | 脂蛋白相关磷脂酶a2(lppla2)测定试剂盒(胶乳增强免疫比浊法) |
CN102628864A (zh) * | 2011-12-30 | 2012-08-08 | 北京九强生物技术股份有限公司 | 胶乳增强免疫比浊法测定血清或尿液中心脏型脂肪酸结合蛋白的试剂盒 |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105181694A (zh) * | 2015-02-27 | 2015-12-23 | 北京利德曼生化股份有限公司 | 癌胚抗原胶乳增强免疫比浊试剂盒及其应用 |
CN105181694B (zh) * | 2015-02-27 | 2020-04-03 | 北京利德曼生化股份有限公司 | 癌胚抗原胶乳增强免疫比浊试剂盒 |
CN105911293A (zh) * | 2016-05-26 | 2016-08-31 | 安徽伊普诺康生物技术股份有限公司 | 一种测定免疫球蛋白a的试剂盒及其制备方法 |
CN106018299A (zh) * | 2016-05-26 | 2016-10-12 | 安徽伊普诺康生物技术股份有限公司 | 一种测定血清淀粉样蛋白a的试剂盒及其制备方法 |
CN106093418A (zh) * | 2016-05-26 | 2016-11-09 | 安徽伊普诺康生物技术股份有限公司 | 一种测定肌钙蛋白i的试剂盒及其制备方法 |
CN106093423A (zh) * | 2016-05-31 | 2016-11-09 | 安徽伊普诺康生物技术股份有限公司 | 一种测定视黄醇结合蛋白的试剂盒及其制备方法 |
CN106053839A (zh) * | 2016-07-12 | 2016-10-26 | 安徽伊普诺康生物技术股份有限公司 | 一种测定结合珠蛋白的试剂盒及其制备方法 |
CN106353507A (zh) * | 2016-08-24 | 2017-01-25 | 武汉生之源生物科技股份有限公司 | 一种检测血清淀粉样蛋白的试剂盒及其用途 |
CN107102150A (zh) * | 2017-05-04 | 2017-08-29 | 上海奥普生物医药有限公司 | 一种尿微量白蛋白测定试剂盒及其制备方法 |
CN107478846A (zh) * | 2017-08-10 | 2017-12-15 | 迈克生物股份有限公司 | 一种免疫球蛋白g检测试剂盒及检测方法 |
CN107490676A (zh) * | 2017-08-10 | 2017-12-19 | 迈克生物股份有限公司 | 一种补体c3检测试剂盒及检测方法 |
CN107490675A (zh) * | 2017-08-10 | 2017-12-19 | 迈克生物股份有限公司 | 一种免疫比浊试剂盒及检测方法 |
CN107478853B (zh) * | 2017-08-10 | 2018-10-12 | 迈克生物股份有限公司 | 一种载脂蛋白b检测试剂盒及检测方法 |
CN107478846B (zh) * | 2017-08-10 | 2018-11-23 | 迈克生物股份有限公司 | 一种免疫球蛋白g检测试剂盒及检测方法 |
CN107478853A (zh) * | 2017-08-10 | 2017-12-15 | 迈克生物股份有限公司 | 一种载脂蛋白b检测试剂盒及检测方法 |
CN107490675B (zh) * | 2017-08-10 | 2019-02-12 | 迈克生物股份有限公司 | 一种免疫比浊试剂盒及检测方法 |
CN107741492A (zh) * | 2017-09-30 | 2018-02-27 | 安徽伊普诺康生物技术股份有限公司 | 一种包被有n‑端脑利钠肽前体抗体的胶乳微球的制备方法 |
CN108548927A (zh) * | 2018-03-30 | 2018-09-18 | 武汉生之源生物科技股份有限公司 | 消除血清脂类干扰的胶乳免疫比浊法胃蛋白酶原ⅱ检测试剂盒及其制备方法 |
CN108956982A (zh) * | 2018-07-09 | 2018-12-07 | 广州华澳生物科技有限公司 | 一种类风湿性关节炎标志物联合定量检测试纸及其制备方法 |
CN109001463A (zh) * | 2018-07-09 | 2018-12-14 | 广州华澳生物科技有限公司 | 一种胃癌风险标志物联合定量检测试纸及制备方法 |
CN109001464A (zh) * | 2018-07-09 | 2018-12-14 | 广州华澳生物科技有限公司 | 一种炎症标志物联合定量检测试纸及其制备方法 |
CN109856067A (zh) * | 2019-01-11 | 2019-06-07 | 河北省医疗器械与药品包装材料检验研究院(河北省医疗器械技术审评中心) | 一种c反应蛋白测定试剂盒 |
CN110007091A (zh) * | 2019-04-02 | 2019-07-12 | 杭州博谱医药科技有限公司 | 一种脂联素检测试剂盒及其制备方法 |
CN110372783A (zh) * | 2019-04-15 | 2019-10-25 | 杭州博谱医药科技有限公司 | 一种脂联素抗原、抗体及其胶乳试剂的制备方法以及脂联素检测试剂盒 |
CN111239421A (zh) * | 2020-02-19 | 2020-06-05 | 安徽大千生物工程有限公司 | 一种定量检测脂联素adpn的胶乳增强免疫比浊试剂盒及其制备与应用方法 |
CN111337692A (zh) * | 2020-03-25 | 2020-06-26 | 江西乐成生物医疗有限公司 | 一种脂联素测定试剂及制备方法 |
CN111337692B (zh) * | 2020-03-25 | 2023-10-03 | 江西乐成生物医疗有限公司 | 一种脂联素测定试剂及制备方法 |
CN111505317A (zh) * | 2020-04-21 | 2020-08-07 | 江西乐成生物医疗有限公司 | 脂联素测定试剂质控品及制备方法 |
CN111505317B (zh) * | 2020-04-21 | 2023-09-29 | 江西乐成生物医疗有限公司 | 脂联素测定试剂质控品及制备方法 |
CN112730827A (zh) * | 2020-12-11 | 2021-04-30 | 常州爱复康生物科技有限公司 | 一种新型冠状病毒抗体检测试剂盒及其制备方法 |
CN113049836A (zh) * | 2021-03-10 | 2021-06-29 | 深圳上泰生物工程有限公司 | 一种组合物及其脂联素检测试剂盒 |
CN114112957A (zh) * | 2021-11-26 | 2022-03-01 | 浙江夸克生物科技有限公司 | 一种脂联素测定试剂盒及其应用 |
CN114295840A (zh) * | 2021-12-29 | 2022-04-08 | 中元汇吉生物技术股份有限公司 | 一种高灵敏度定量测定脂联素的试剂盒及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104237522B (zh) | 2016-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104237522A (zh) | 脂联素含量检测试剂盒及其制备方法 | |
CN104237525B (zh) | 一种用于测定降钙素原的胶乳增强免疫比浊试剂盒及其制备方法和应用 | |
CN104977404B (zh) | 抑制类风湿因子干扰的胶乳增强免疫比浊试剂 | |
CN103123319B (zh) | 心型脂肪酸结合蛋白含量检测试剂盒及其制备方法 | |
CN108279309A (zh) | 一种pla2r抗体的检测试纸条及检测方法 | |
CN106932589A (zh) | 测定人体血清视黄醇结合蛋白含量的试剂盒及其制备方法 | |
CN104198723A (zh) | 一种基于氨基酸间臂的ngal快速检测试剂盒 | |
CN107340395A (zh) | 一种检测降钙素原的免疫比浊试剂盒 | |
CN106198961A (zh) | 一种定量检测血清淀粉样蛋白a的乳胶增强免疫比浊试剂盒及其制备方法 | |
CN105067615B (zh) | 一种基于酰胺基团纳米胶乳增强比浊法动物c‑反应蛋白的检测试剂盒及检测方法 | |
CN109085333A (zh) | 一种类风湿因子抗原的制备、检测试剂盒及制备方法 | |
CN107102150A (zh) | 一种尿微量白蛋白测定试剂盒及其制备方法 | |
CN102662064A (zh) | 检测中性粒细胞明胶酶相关脂质运载蛋白的免疫比浊试剂盒及其制备方法 | |
CN103698525A (zh) | 一种消除乳糜干扰的胶乳免疫比浊法胃蛋白酶原ⅰ检测试剂盒 | |
CN103323596B (zh) | 髓过氧化物酶含量检测试剂盒及其制备方法 | |
CN104614528A (zh) | 一种线性范围更宽的视黄醇结合蛋白测定试剂盒 | |
CN102628866B (zh) | 利用igy型铁蛋白抗体、通过胶乳增强免疫比浊法测定血清中铁蛋白的液体双试剂试剂盒 | |
CN105467131A (zh) | 可以同时检测尿液和血清样本中α1-微球蛋白的试剂盒 | |
WO2021088730A1 (zh) | 游离前列腺特异性抗原检测试剂盒及其制备方法 | |
WO2021147453A1 (zh) | 一种粘液病毒抗性蛋白1的定量试剂盒 | |
CN103308681B (zh) | 胰蛋白酶原-2检测试剂盒及制备方法 | |
CN110702926A (zh) | 一种胃泌素g17检测试剂盒及其制备方法 | |
CN106771152A (zh) | 一种快速检测钙卫蛋白的试剂盒 | |
CN102809654A (zh) | 一种双粒子复合的c-反应蛋白检测试剂盒 | |
CN107228940A (zh) | 一种胱抑素c的检测试剂及方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 430223 B11 building, No. 818, hi tech medical center, hi tech Avenue, East Lake Development Zone, Wuhan, Hubei, 2 Applicant after: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Address before: 430223 Hubei city of Wuhan province East Lake Development Zone Road, University of Wuhan University of science and Technology Park building four floor Applicant before: Wuhan Life Origin Biotech Co., Ltd. |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Adiponectin content detection kit and preparation method thereof Effective date of registration: 20180612 Granted publication date: 20161221 Pledgee: Wuhan rural commercial bank Limited by Share Ltd Optics Valley branch Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Registration number: 2018420000024 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190620 Granted publication date: 20161221 Pledgee: Wuhan rural commercial bank Limited by Share Ltd Optics Valley branch Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Registration number: 2018420000024 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Adiponectin content detection kit and preparation method thereof Effective date of registration: 20190813 Granted publication date: 20161221 Pledgee: Wuhan rural commercial bank Limited by Share Ltd Optics Valley branch Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Registration number: Y2019420000004 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201223 Granted publication date: 20161221 Pledgee: Guanggu Branch of Wuhan Rural Commercial Bank Co.,Ltd. Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK Co.,Ltd. Registration number: Y2019420000004 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |